- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
ACOG Strengthens Recommendation for Bilateral Salpingectomy to Prevent Ovarian Cancer

The American College of Obstetricians and Gynecologists (ACOG) has strengthened its recommendation that bilateral salpingectomy be routinely considered during hysterectomy, particularly when the ovaries are being preserved, to reduce lifetime risk of ovarian cancer.
• Bilateral fallopian-tube removal is considered a safe and effective risk-reduction strategy without removing the ovaries.
• The recommendation reflects growing evidence that many high-grade serous “ovarian” cancers originate in the fallopian tubes.
• OB/GYNs are also encouraged to collaborate with other surgical specialties to consider opportunistic salpingectomy during appropriate non-gynecologic pelvic or abdominal procedures.
• Preserving the ovaries avoids the consequences of surgical menopause associated with bilateral salpingo-oophorectomy.
Clinical implication: Opportunistic bilateral salpingectomy is increasingly viewed as a practical ovarian-cancer prevention strategy for women undergoing pelvic surgery, while ovarian conservation can preserve hormonal function.
ACOG today released updated guidance outlining the strong data supporting bilateral salpingectomy, or removal of both fallopian tubes, as a safe and effective method of reducing patients’ lifetime risk of ovarian cancer.
The burden of ovarian cancer remains high, with an estimated 20,890 incident cases and 12,730 attributable deaths in 2025, according to the National Cancer Institute. There is currently no effective screening for ovarian cancer. Symptoms of ovarian cancer can be vague—such as a feeling of abdominal fullness, changes in appetite, and pelvic pain-which often contributes to delays in diagnosis. Most patients are diagnosed when the disease has already spread to other organs, making successful treatment difficult.
Understanding of the origins of ovarian cancer has evolved over time. Robust data support salpingectomy as an important risk-reduction strategy, as most ovarian cancers actually begin in the fallopian tubes. Removal of both fallopian tubes can reduce the risk of ovarian cancer by as much as 78%.
“Having cared for many women with ovarian cancer, I understand deeply the tremendous toll that complex surgery and multiple rounds of intensive chemotherapy can take on patients and their loved ones,” said Sandra E. Brooks, MD, MBA, FACOG, chief executive officer at ACOG. “Although advances in treatment have helped patients live longer, mortality from ovarian cancer remains high. Salpingectomy represents a meaningful opportunity to reduce a person’s risk of ever having to contend with this challenging disease.”
The updated guidance explains how common procedures inside the abdomen or pelvis, including hysterectomy, tubal procedures for permanent contraception, and non-gynecologic surgeries, offer opportunities for patients to reduce their risk of ovarian cancer through salpingectomy.
ACOG’s updated guidelines recommend that ob-gyns should routinely perform bilateral salpingectomy at the time of hysterectomy. The update also states that bilateral salpingectomy should be recommended to patients who do not desire future fertility and are undergoing non-hysterectomy gynecologic surgery that enters the peritoneal cavity.
Although ACOG previously recommended that the route of surgery should not be changed to facilitate salpingectomy, ACOG now recommends that obstetrician–gynecologists should consider successful completion of salpingectomy when counseling patients about potential surgical approaches. This change is based on the strength of the body of data supporting salpingectomy to reduce the risk of ovarian cancer. The update emphasizes that all treatment decisions should be based on the principles of informed consent and shared decision making.
ACOG’s updated guidance underscores that permanent contraception procedures are a good opportunity to decrease patients’ risk of ovarian cancer. Tubal sterilization by occlusion of the fallopian tubes or partial salpingectomy has traditionally been performed for patients desiring permanent contraception. ACOG’s updated guidance stresses that complete, bilateral salpingectomy is the preferred procedure for patients desiring permanent contraception, based on safety, efficacy, and cancer risk reduction.
The updated guidance also highlights the importance of cross-specialty collaboration in reducing patients’ risk of ovarian cancer. Other non-gynecologic abdominal or pelvic surgeries may be good opportunities for patients to reduce their risk of ovarian cancer by choosing salpingectomy. Adding salpingectomy to other surgical procedures often incurs minimal risk to the patient while preventing them from needing another surgery. ACOG therefore recommends collaboration between gynecologists and non-gynecologic surgeons of other specialties to improve patients’ access to this potentially life-saving procedure.
“ACOG’s updated guidance represents the strongest recommendations to date supporting patients’ access to salpingectomy to reduce their lifetime risk of ovarian cancer. Obstetrician–gynecologists have an opportunity to empower patients through education, evidence-based practice, and collaboration with other medical and surgical specialists. For now, salpingectomy is the safest, most effective way to prevent this deadly disease,” said David Shalowitz, MD, MSHP, FACOG, co-author of the update.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

